Wilson Sonsini advised NAPIGEN on the deal. NAPIGEN, a company developing proprietary technology to edit mitochondrial and chloroplast genomes, announced the completion of $7.85 million seed...
You must be a Standard 1 Year member to access this content.
Hogan Lovells acted as the U.S. legal counsel to AMTD Global Markets Limited, Maxim Group LLC and Tiger Brokers (NZ) Limited. Wilson Sonsini Goodrich & Rosati...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Matchwell on the deal. Medical Solutions, one of the nation’s largest providers of total workforce solutions serving the healthcare industry,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Flexe on the deal. Flexe, the programmatic logistics leader, announced a $119 million Series D financing round at a $1...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Current Foods on the deal. Current Foods, a California-based start-up of plant-based seafood, announced it has raised $18 million in seed financing. The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Respiratory Motion on the deal. Senzime completed the acquisition of 100 percent of the shares in Respiratory Motion, as was made public on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Kedalion Therapeutics on the deal. Novartis announced that it acquired Kedalion Therapeutics and its AcuStream technology, an innovative device that may have the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Goodwin advised MiroBio on the deal. MiroBio, a leader in the development of checkpoint agonists to treat autoimmune diseases, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cleartrace on the deal. Cleartrace, a leading carbon and energy management software company, announced that it has raised $20 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented ReCode Therapeutics in the transaction. ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised LinkedIn on the deal. LinkedIn announced that it entered into an agreement to acquire EduBrite, a platform that specializes in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised CellPoint on the deal. Walder Wyss has advised +ND Capital, while Baker McKenzie advised CellPoint and AboundBio. Galapagos, a fully...
You must be a Standard 1 Year member to access this content.
